Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,891,000 | 846,000 | 2,940,000 | 3,021,000 | 2,033,000 |
| Depreciation Amortization | 296,000 | 126,000 | 471,000 | 355,000 | 240,000 |
| Income taxes - deferred | -43,000 | -52,000 | -1,330,000 | -195,000 | -186,000 |
| Accounts receivable | -157,000 | -47,000 | -236,000 | -139,000 | -75,000 |
| Other Working Capital | -818,000 | -471,000 | 2,171,000 | -245,000 | -38,000 |
| Other Operating Activity | -265,000 | -727,000 | 1,230,000 | 760,000 | 495,000 |
| Operating Cash Flow | $904,000 | $-325,000 | $5,246,000 | $3,557,000 | $2,469,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -168,000 | -88,000 | -279,000 | -176,000 | -132,000 |
| Net Acquisitions | -8,648,000 | -8,648,000 | N/A | N/A | N/A |
| Purchase Of Investment | -265,000 | -180,000 | -8,573,000 | -7,108,000 | -3,567,000 |
| Sale Of Investment | 3,295,000 | 3,258,000 | 5,988,000 | 3,322,000 | 2,084,000 |
| Other Investing Activity | 0 | 0 | -27,000 | -27,000 | 0 |
| Investing Cash Flow | $-5,786,000 | $-5,658,000 | $-2,891,000 | $-3,989,000 | $-1,615,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,929,000 | 1,815,000 | N/A | 0 | 0 |
| Debt Issued | 4,452,000 | 4,452,000 | 3,468,000 | 496,000 | 0 |
| Debt Repayment | N/A | N/A | -1,904,000 | -500,000 | N/A |
| Common Stock Repurchased | -6,096,000 | -2,700,000 | -3,833,000 | -925,000 | -811,000 |
| Other Financing Activity | -3,928,000 | -1,811,000 | 685,000 | 637,000 | 387,000 |
| Financing Cash Flow | $-643,000 | $1,756,000 | $-1,584,000 | $-292,000 | $-424,000 |
| Exchange Rate Effect | 15,000 | 33,000 | 72,000 | 65,000 | 60,000 |
| Beginning Cash Position | 7,013,000 | 7,013,000 | 6,170,000 | 6,170,000 | 6,170,000 |
| End Cash Position | 1,503,000 | 2,819,000 | 7,013,000 | 5,511,000 | 6,660,000 |
| Net Cash Flow | $-5,510,000 | $-4,194,000 | $843,000 | $-659,000 | $490,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 904,000 | -325,000 | 5,246,000 | 3,557,000 | 2,469,000 |
| Capital Expenditure | -168,000 | -88,000 | -279,000 | -176,000 | -132,000 |
| Free Cash Flow | 736,000 | -413,000 | 4,967,000 | 3,381,000 | 2,337,000 |